Ask Warren

Tdspharm

464280 · KOSDAQ · ₩464280 · 티디에스팜

₩4,715▲ ₩30 (0.64%)End-of-day · Oct 28, 2026 · End-of-day prices.
Trade
Alert me
SellBuy
AnnualQuarterly

Income statement

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Revenue₩8.1B₩8.1B₩8.7B₩8.1B₩5.6B₩5.3B₩5.6B
Cost of sales₩6.2B₩5.8B₩6.2B₩5.5B₩4.3B₩4.1B₩4.2B
Gross profit₩1.9B₩2.3B₩2.5B₩2.5B₩1.3B₩1.2B₩1.4B
Operating income₩1B₩1.3B₩1.6B₩1.6B₩323M₩189M₩297M
Net income−₩187M₩1.1B₩2.8B₩601M₩493M₩366M₩2.9B
Net income to shareholders−₩187M₩1.1B₩2.8B₩601M₩493M₩366M₩2.9B

Balance sheet

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Total assets₩64B₩62B₩54B₩52B₩50B₩49B₩49B
Current assets₩37B₩37B₩30B₩39B₩37B₩36B₩40B
Cash and equivalents₩2.8B₩3.3B₩1.2B₩15B₩9B₩5.4B₩4.7B
Total liabilities₩19B₩18B₩11B₩10B₩10B₩9.7B₩11B
Current liabilities₩19B₩18B₩11B₩10B₩10B₩9.5B₩11B
Borrowings₩14B₩14B₩0₩6.4B₩475M₩475M₩775M
Total equity₩45B₩44B₩43B₩41B₩40B₩39B₩39B
Shareholders' equity₩45B₩44B₩43B₩41B₩40B₩39B₩39B

Cash flow

Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
Cash from operations₩1.5B₩2.3B₩795M₩1.9B−₩34M₩1.1B−₩883M
Free cash flow₩1.5B₩2.3B₩795M₩1.9B−₩34M₩1.1B−₩883M

Consolidated where available. Amounts in won.

Also known as: Tdspharm / 티디에스팜 / 464280 / KRX:464280

Source: KRX statistical information